LEADER 03635nam 2200529Ia 450 001 9910741193503321 005 20200520144314.0 010 $a1-4614-6608-3 024 7 $a10.1007/978-1-4614-6608-6 035 $a(CKB)2550000001044170 035 $a(EBL)1205337 035 $a(SSID)ssj0000880271 035 $a(PQKBManifestationID)11456405 035 $a(PQKBTitleCode)TC0000880271 035 $a(PQKBWorkID)10873106 035 $a(PQKB)11257781 035 $a(DE-He213)978-1-4614-6608-6 035 $a(MiAaPQ)EBC1205337 035 $a(PPN)169136450 035 $a(EXLCZ)992550000001044170 100 $a20130313d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aMerkel cell carcinoma /$fMurad Alam 205 $a1st ed. 2013. 210 $aNew York $cSpringer$d2013 215 $a1 online resource (219 p.) 300 $aDescription based upon print version of record. 311 $a1-4614-6607-5 327 $aPART 1. BASIC SCIENCE AND EPIDEMIOLOGY -- Chapter 1. Basic Science of the Merkel Cell -- Chapter 2. Epidemiology and Genetics (including high risk pts, polyomavirus, prognostic factors) -- PART 2. DIAGNOSIS -- Chapter 3. Clinical Diagnosis -- Chapter 4. Staging -- Chapter 5. Histologic Diagnosis -- PART 3. THERAPY -- Chapter 6. Local Excision (primary, recurrent disease) -- Chapter 7. Lymph Node Procedures of the Head and Neck -- Chapter 8. Lymph Node Procedures of the Trunk and Extremities -- Chapter 9. Radiation Therapy (primary and recurrent disease) -- Chapter 10. Chemotherapy (primary and recurrent disease) -- Chapter 11. Treatment Algorithm (NCCN guidelines, etc) -- PART 4. EXPERT OPINIONS AND FUTURE DIRECTIONS -- Chapter 12. Case Study A: Multiply Recurrent Merkel Cell Carcinoma -- Chapter 13. Case Study B: Radiation monotherapy for extensive local and in-transit Merkel cell carcinoma -- Chapter 14. Case Study C: Complete spontaneous regression of Merkel cell carcinoma metastatic to the liver -- Chapter 15. Case Study D: Evaluation of multiple Merkel cell carcinomas in a single patient -- Chapter 16. Case Study E: Multidisciplinary Management of Merkel Cell Carcinoma -- Chapter 17. Emerging Prognostic and Therapeutic Approaches. 330 $aMerkel Cell Carcinoma is one of the first comprehensive, single-source clinical texts on the subject. Although not as common as melanoma, Merkel cell carcinoma is not rare ? and it is both more deadly than melanoma and increasing at an epidemic rate. The book is clinical in focus and emphasizes treatment of this poorly understood cancer. Contributing authors include dermatologists, surgical oncologists, radiation oncologists, and medical oncologists from the US and around the world. Features: Comprehensive single-source clinical reference Treatment focus Written for practitioners, with emphasis on clinical relevance and quick retrieval of information Contributing authors represent all disciplines involved in treatment of Merkel cell carcinoma: dermatology, surgical oncology, radiation oncology, and medical oncology International in perspective, with contributors from US and abroad Members of active Merkel Cell Carcinoma Multicenter Interest Group have authored some of the chapters. 606 $aMerkel cells 606 $aCancer 615 0$aMerkel cells. 615 0$aCancer. 676 $a616.99488 700 $aAlam$b Murad$01620311 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910741193503321 996 $aMerkel cell carcinoma$94200575 997 $aUNINA